Partner Therapeutics
PrivateLast Round
Grant
Feb 17, 2022
Total Funding Raised
$100M
Company Overview
Partner Therapeutics is a biopharmaceutical company that develops and commercializes therapies for cancer and other serious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Partner Therapeutics Comparables
Compare Partner Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Merus N.V. | 85% | |
| Amgen | 77% | |
| Teva Pharmaceuticals | 76% | |
Partner Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Feb 17, 2022 | ||||
| Grant | Aug 4, 2020 | ||||
| Series A | Feb 1, 2018 |
Partner Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Perceptive Advisors | Series A |
| U.S. Department of War | Grant |
| Adams Street Partners | Series A |
| MidCap Financial | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 11, 2025
Monthly visitors increased 72% MoM.
- Jan 25, 2025
Monthly visitors grew 167% MoM, reaching 4K.
Partner Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Partner Therapeutics's valuation, stock price, and market status.